Prognostic value of cyclin E and p53 expression in gastric carcinoma

Cancer

Volumn 82, Issue 7, 1998, Pages 1238-1243

  Sakaguchi, Teruyuki ^a   Watanabe, Akihiko ^a   Sawada, Hidetomo ^a   Yamada, Yukishige ^a   Yamashita, Jun ^a   Matsuda, Masahiko ^a   Nakajima, Masakazu ^a   Miwa, Takeshi ^a   Hirao, Tomoko ^a   Nakano, Hiroshige ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell cycle; Cyclin E; Gastric carcinoma; Immunohistochemistry; P53; Prognosis

Indexed keywords

CYCLIN E; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOGENICITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CARCINOMA; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CYCLIN E; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032055552     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980401)82:7<1238::AID-CNCR5>3.0.CO;2-B     Document Type: Article

References (32)

1. Pines J, Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin m RNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 1989;58:833-46.
2. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992;257:1689-94.
3. Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 1991;66:1197-206.
4. Xiong Y, Connolly T, Futeher B, Beach D. Human D-type cyclin. Cell 1991;65:691-9.
5. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
6. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991;65:701-13.
7. Keyormarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994;54:380-5.
8. Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995;147:545-60.
9. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992;52:2980-3.
10. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8:2127-33.
11. Leach SF, Elledge SJ, Sherr CJ, Wilson JK, Markowitz S, Kinzler KW, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53:1986-9.
12. Michalides R, van Veelen N, Hart A, Loftus B, Wienjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
13. Nikaido T, Li SF, Shiozawa T, Fujii S. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer 1996;78:1248-53.
14. Kitahara K, Yasui W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, et al. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 1995;62:25-8.
15. Nielsen NH, Arnerloev C, Emdin SO, Landberg G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 1996;74:874-80.
16. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222-5.
17. Li SF, Shiozawa T, Nakayama K, Nikaido T, Fujii S. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer 1996;77:321-9.
18. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995;86:617-21.
19. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, et al. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1996;1:88-94.
20. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-5.
21. 1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
22. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
23. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Matkowitz S, Willson JK, et al. p53 gene mutations occur in combination with 17p alleic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
24. Imazeki F, Omata M, Nose H, Ohto M, Isono K. p53 gene mutations in gastric and esophageal cancers. Gastroenterology 1992;103:892-6.
25. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992;50:859-62.
26. Japanese Research Society for Gastric Cancer. Part I. Clinical, surgical, and conclusive findings. Nishi M, Omori Y, Miwa D, editors. Japanese classification of gastric carcinoma. First English edition. Tokyo: Kanehara & Co, 1995:1-351.
27. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:197-220.
28. Nesnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol Cell Biol 1994;14:1669-79.
29. Wimmel A, Lucibello FC, Sewing A, Adolph S, Mueller R. Inducible acceleration of G1 progression through tetracyclin-regulated expression of human cyclin E. Oncogene 1994;9:995-7.
30. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-7.
31. Bonder SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 1992;7:743-9.
32. Ohtsubo M, Theodoras A, Schumacher I, Robertz J, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995;15:2612-24.